Postbiotic Supplements Market

Market Size (2026)
USD 14.5 Mn
Forecast (2036)
USD 44.2 Mn
CAGR (2026 to 2036)
11.8%

How Big is the Postbiotic Supplements Market in 2026?

From USD 13.0 Million in 2025 and USD 14.5 Million in 2026, postbiotic supplement revenue is projected to reach USD 44.2 Million by 2036, an 11.8% CAGR built on supplement users moving from live cultures to heat-treated formats.

Revenue from postbiotic supplements stood at an estimated USD 13.0 Million in 2025 and is set to reach USD 14.5 Million in 2026, with FMI projecting USD 44.2 Million by 2036 at an 11.8% CAGR. The buyer pool for that growth already exists, as the National Center for Health Statistics reported in May 2026 that 60.2% of US adults aged 20 and older had used a dietary supplement in the past 30 days and 38.7% had taken two or more. Postbiotic brands will grow by moving existing supplement users across from live cultures, and heat-inactivated preparations will give those brands a simpler stability file for the switch than live probiotics.

Set against neighbouring gut-health categories, the USD 29.7 Million that postbiotic supplements will gain between 2026 and 2036 is a small pool. Sales of probiotic supplements will rise from USD 14.6 Billion in 2026 to USD 36.8 Billion by 2036 at a 9.7% CAGR, an opportunity of USD 22.2 Billion, a far larger pool than postbiotics, and conversion from live cultures will come gradually, product line by product line. Demand for immune digestive support products is set to expand from USD 1,560.0 Million to USD 3,527.1 Million at an 8.5% CAGR, a gain of USD 1,967.1 Million, and postbiotic brands with immunity claims will compete for the same shopper budget.

Within Europe, demand for postbiotic supplements in the EU will increase from USD 4.5 Million in 2026 to USD 14.3 Million by 2036 at a 12.3% CAGR, an opportunity of USD 9.8 Million and a faster pace than the global market. FMI expects postbiotics to take share from live probiotics first in formats exposed to heat, moisture or long storage, since those are the products in which a live count is hardest to guarantee. Investment in human studies tied to one named preparation will decide which brands convert existing supplement users into repeat postbiotic buyers through 2036.

Postbiotic Supplements Market Value Analysis chart showing growth from USD 14.5 million in 2026 to USD 44.2 million by 2036 at a CAGR of 11.8%
Postbiotic Supplements Market Value Analysis

Key Takeaways of Postbiotic Supplements Market

  • Capsules and tablets will hold 55.6% of market share in 2026, by form.
  • Online retailing will lead sales channels in 2026, taking 41.2% of revenue as brands use product pages to introduce a new term.
  • Key companies operating in the postbiotic supplements market include DSM-Firmenich, Novonesis, Kerry Group plc, Lallemand Inc., Probi AB, and Kirin Holdings Company, Limited, and the full report covers many more players.
  • The UK will grow fastest at a 13.8% CAGR, and South Korea will grow slowest at 8.5% under formal functional-ingredient rules.

Analyst Perspective

“Postbiotic supplements will move from a niche gut health add-on to a mainstream choice, as consumers look for proven benefits without the storage and survival limits of live probiotics. The biggest opportunity lies in clinically backed strains for immune, digestive and metabolic support sold through online channels, as product pages let brands describe the science and build repeat subscriptions. Suppliers that invest in strain-specific research and country-level health claim approvals will hold the most valuable positions through 2036.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the Postbiotic Supplements Market Segmented?

Postbiotic supplement revenue is split by form and sales channel, with three dose formats and four retail channels tracked across seven regions.

Based on form, the market is segmented into capsules and tablets, soft-gel and chews, and powder and granules. By sales channel, the report covers online retailing, drug stores, health and beauty stores, and modern trade. Finished products draw on supply from the postbiotic ingredients market, and the regional study includes seven regions and 27 countries and country groups.

Why Do Capsules and Tablets Lead the Postbiotic Supplements Market by Form?

Postbiotic Supplements Market Analysis by Form
Postbiotic Supplements Market Analysis by Form

Capsules and tablets will hold 55.6% of form revenue in 2026 in FMI's estimates, as a fixed unit dose suits preparations sold on one clinically studied amount.

A shopper comparing postbiotic labels needs to know how much of one named preparation each serving delivers, and a capsule or tablet answers that question with a fixed unit dose. Contract manufacturers already run encapsulation lines for probiotics, so brands can add a postbiotic product without new filling equipment. Probi launched Rham271h, a heat-inactivated Lacticaseibacillus rhamnosus 271 preparation, in May 2026 and cited enhanced pH, heat and shelf stability. Chews are gaining ground as a second format, and the gummy supplements category is giving postbiotic brands a ready route into taste-led buying.

  • Capsules and tablets will hold 55.6% of form revenue in 2026, with dose control and existing encapsulation capacity keeping the format ahead of chews and powders.
  • In July 2026, Japan's Consumer Affairs Agency confirmed that GMP-based manufacturing control for supplement-form Foods with Function Claims would apply from September 1, 2026.

Why Does Online Retailing Lead the Postbiotic Supplements Market by Sales Channel?

Online retailing will carry 41.2% of postbiotic supplement revenue in 2026, as product pages and subscriptions give a new category room to build repeat orders.

Most shoppers will meet the word postbiotic for the first time on a label or a search result, and many will confuse the term with probiotic. A product page gives a brand space to set out the preparation, the dose and the study behind a claim before the first purchase, and a subscription keeps a daily-use product in the basket without a repeat shelf decision. Marketplace scrutiny of health claims is a key challenge, owing to which brands holding preparation-specific evidence will keep listings longer.

  • Online retailing will hold 41.2% of sales channel revenue in 2026, ahead of drug stores, health and beauty stores and modern trade.
  • In February 2026, Kerry published a four-week US consumer perception study of the Plenibiotic postbiotic among GLP-1 users. Medication users of this kind form a defined audience that postbiotic brands will reach through targeted online campaigns.

What are the Drivers, Restraints, and Opportunities in the Postbiotic Supplements Market?

Shelf stability and daily supplement habits will lift sales, and FMI sees country rules on ingredient status and claims as the main brake on launches, with need-specific postbiotics for digestion and immunity opening a higher-value revenue pool till 2036.

  • Driver: Heat-inactivated preparations let brands offer gut and immune support without managing a live count through heat, transport and storage.
  • Restraint: Ingredient status, claim wording and evidence rules differ by country, adding qualification cost and delaying launches.
  • Opportunity: Need-specific postbiotics for digestive comfort, immunity and healthy aging open premium lines, and postbiotic ferment filtrates add a second ingredient route for formulators.

Lallemand Health Solutions agreed in May 2025 to distribute IMMUSE, the heat-inactivated Lactococcus lactis strain Plasma developed by Kirin, for immune support. In April 2026, Lallemand said IMMUSE would feature in a Vitafoods Barcelona line-up spanning four health areas. Each of these moves widens access to a named preparation, yet the scientific term postbiotic does not create one regulatory category, so a brand selling in several countries will file a separate dossier for each. Human data for the named preparation, format support and country-ready claims are becoming the three tests a supplier passes before a brand signs, and qualification cost will fall hardest on smaller brands entering more than one market.

Which Country CAGRs are Profiled in the Postbiotic Supplements Market?

Postbiotic Supplements Market Growth by Market map showing country CAGRs for 2026 to 2036: UK 13.8%, Germany 13.2%, Japan 11.9%, USA 9.5%, South Korea 8.5%
Postbiotic Supplements Market Growth by Market
Country CAGR, 2026 to 2036
UK 13.8%
Germany 13.2%
Japan 11.9%
USA 9.5%
South Korea 8.5%

How do Country-level CAGRs Compare in the Postbiotic Supplements Market?

FMI's country forecasts place the two European markets at the top, with the UK at a 13.8% CAGR and Germany at 13.2%, both above the 11.8% global rate. Japan sits close to the global pace at 11.9%, and the USA at 9.5% and South Korea at 8.5% close the ranking, leaving a 5.3 percentage-point gap between the fastest and slowest profiled country. Slower growth in the USA will reflect a mature buyer base, so sizeable absolute revenue gains through 2036 can still come from a country lower in the ranking.

  • Sales in the UK will record the highest CAGR, even though the word probiotic still counts as an unauthorized health claim on UK packs.
  • German pharmacy buyers will reward documentation depth, lifting demand at a 13.2% CAGR under EU rules that admit only authorized health-claim wording.
  • Supplement-form Foods with Function Claims in Japan will run under GMP-based manufacturing control from September 2026, framing an 11.9% CAGR.
  • At 8.5%, South Korea sits 5.3 points below the UK, as functional-ingredient recognition gates every new function claim.

FMI also tracks regional CAGRs for North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa. Country coverage runs to 27 countries and country groups in total, including the five profiled here.

Country Outlook

  • UK growth at a 13.8% CAGR, the fastest among profiled countries, is building on a supplement rulebook that is still under debate. The Food Standards Agency published updated food supplements guidance in June 2026. In September 2026, the Health Food Manufacturers' Association asked the Health Secretary to allow the term probiotic on pack, as 11 EU countries already do. A change in that rule will sharpen the contrast between live and heat-treated products on shelf and give postbiotic brands clearer category language.
  • German pharmacy buyers will expect documentation before listing a microbiome product, and the country's 13.2% CAGR till 2036 will track how fast brands assemble that file. Health claims follow the EU authorization framework, so microbiome language on pack needs approved wording and generally accepted evidence. Probi, part of the German flavors, nutrition and fragrances group Symrise since 2025, reports more than 450 scientific publications across the company's strains. A supplier carrying that depth of literature into a postbiotic launch will shorten qualification with German retail and pharmacy accounts.
  • Japan pairs an 11.9% CAGR through 2036 with a manufacturing deadline that has already taken effect for supplement makers. The Consumer Affairs Agency confirmed in July 2026 that GMP-based manufacturing control for supplement forms would apply from September 1. Domestic strain owners are also exporting home-market evidence, as Kirin's heat-inactivated strain Plasma reaches buyers abroad as IMMUSE through a May 2025 distribution agreement with Lallemand.
  • In the USA, a large existing buyer base will hold growth to a 9.5% CAGR till 2036 and still give brands a deep pool of supplement users to convert. NCHS data published in May 2026 show that 66.1% of US women and 53.9% of men aged 20 and over used a dietary supplement in the past 30 days. Kerry's February 2026 Plenibiotic study tracked digestive comfort among US GLP-1 users over four weeks, pointing brands toward a defined medication-user segment.
  • A recognition dossier stands between any new postbiotic and a function claim in South Korea, and growth will hold at an 8.5% CAGR, the slowest among profiled countries. The Ministry of Food and Drug Safety registered Regulation No. 2026-33 in August 2026, covering recognition of functional ingredients and standards for health functional foods. Health functional food labels carry only recognized functions, so early movers with an approved ingredient will keep shelf positions for longer.

Who are the Notable Companies in the Postbiotic Supplements Market?

Key companies in the market include DSM-Firmenich, Novonesis, Kerry Group plc, Lallemand Inc., Probi AB, and Kirin Holdings Company, Limited.

Postbiotic Supplements Market Company Highlight
Postbiotic Supplements Market Company Highlight

Supply of named postbiotic preparations is concentrated among a handful of biotics groups, and competition turns on the human data attached to each preparation. Integrated platforms such as DSM-Firmenich and Novonesis are folding postbiotics into wider probiotic and prebiotic portfolios, and Novonesis lists Pylopass in powder form within the gastrointestinal health range of the Human Health portfolio. Entry barriers sit in strain ownership and clinical files, owing to which probiotic specialists are converting existing strains into heat-inactivated versions, as Probi did with Rham271h in May 2026. Kerry is building evidence around specific user groups, and the company published a US consumer perception study of Plenibiotic among GLP-1 users in February 2026. Consolidation and licensing are reshaping access, with Probi now part of Symrise and Lallemand distributing the Kirin strain IMMUSE under a May 2025 agreement.

In FMI's view, price pressure will build on undifferentiated postbiotic ingredients through 2036 as more probiotic suppliers launch heat-treated versions of existing strains. Holders of strain-specific clinical data, country-level health claim approvals and licensing partnerships will keep pricing power, and a brand switching away from such a supplier will face a fresh qualification cycle.

  • Integrated Biotics Platforms: DSM-Firmenich and Novonesis pair postbiotics with probiotics, formulation support and consumer-format development, and Humiome Post LB now comes in an allergen-free version for gummies.
  • Postbiotic Ingredient Specialists: Kerry Group plc, Lallemand Inc. and Probi AB sell named postbiotics tied to digestive comfort, immunity or stability claims.
  • Strain Owners and Licensors: Kirin Holdings Company, Limited developed the heat-inactivated Lactococcus lactis strain Plasma and reaches markets outside Japan through the IMMUSE agreement with Lallemand.

Competitive Benchmarking

Company Postbiotic Portfolio Format Enablement Clinical Documentation Geographic Reach
DSM-Firmenich High High High Global nutrition and biotics footprint
Novonesis Medium High Medium Global Human Health platform
Kerry Group plc Medium High High Americas, Europe and global supplement customers
Lallemand Inc. Medium High High Global biotics platform
Probi AB Medium High Medium EMEA, Americas and APAC
Kirin Holdings Company, Limited Low Medium High Japan, with wider reach through Lallemand

Key Developments

  • In May 2025, Lallemand Health Solutions and Kirin Holdings announced a distribution agreement for IMMUSE, the heat-inactivated Lactococcus lactis strain Plasma positioned for immune support.
  • In February 2026, Kerry published a US consumer perception study of Plenibiotic among GLP-1 users, positioning the postbiotic for digestive comfort.
  • In May 2026, Probi AB launched Rham271h, the company's first postbiotic, at Vitafoods Europe, citing enhanced pH, heat and shelf stability.

Key Players

Integrated Biotics Platforms

  • DSM-Firmenich
  • Novonesis

Postbiotic Ingredient Specialists

  • Kerry Group plc
  • Lallemand Inc.
  • Probi AB

Strain Owners and Licensors

  • Kirin Holdings Company, Limited

Report Scope and Methodology

Coverage field Report scope
Market breakdown 2 categories: Form (Capsules and Tablets, Soft-gel and Chews, Powder and Granules), Sales Channel (Online Retailing, Drug Store, Health and Beauty Store, Modern Trade), and Region
Quantitative units USD Million
Market definition Revenue from finished supplements whose primary active is a postbiotic, meaning an inanimate microbial preparation sold for a health benefit, within the stated Form and Sales Channel segmentation. The definition excludes postbiotic ingredients used in conventional foods, beverages, medical nutrition, pharmaceuticals and pet products, as well as probiotic, prebiotic and synbiotic supplements.
Regions covered North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered 27 countries and country groups, with profiled CAGRs for the UK, Germany, Japan, the USA, and South Korea
Key companies profiled Among the many players covered, notable companies include DSM-Firmenich, Novonesis, Kerry Group plc, Lallemand Inc., Probi AB, and Kirin Holdings Company, Limited
Forecast period 2026 to 2036
Approach A hybrid bottom-up and top-down sizing framework reconciles postbiotic supplement volumes, pricing by form and channel, and supplier revenue signals with supplement-use indicators in each country.

Research Methodology

Method Approach
Primary research Primary research engages supplement brand owners, postbiotic ingredient suppliers, contract manufacturers, distributors, pharmacy and online retail buyers and nutrition specialists to test purchase drivers, format choices, claim requirements, pricing and repeat-purchase conditions.
Desk research The analysis reviews national health surveys, supplement and functional food rules, regulator notices, company announcements and product pages. Only sources that define demand, product format, country conditions or supplier activity inside the market boundary are retained.
Market sizing and forecasting The sizing framework combines the baseline value with form and channel structure, price and volume indicators, company participation and country-level supplement use. Forecasts consider launches, claim rules, manufacturing requirements and competition from live probiotics.
Data validation Estimates are checked against public data, company activity and interview findings. Postbiotic ingredients sold into foods and beverages, adjacent biotics, overlapping revenues and unsupported claims are excluded before final reconciliation.

Postbiotic Supplements Market by Segments

Postbiotic Supplements Market Segmented by Form

  • Capsules and Tablets
  • Soft-gel and Chews
  • Powder and Granules

Postbiotic Supplements Market Segmented by Sales Channel

  • Online Retailing
  • Drug Store
  • Health and Beauty Store
  • Modern Trade

Postbiotic Supplements Market Segmented by Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa

Research Sources and Bibliography

  • [1] National Center for Health Statistics (2026, May 21). Dietary Supplement Use: United States, August 2021-August 2023. NCHS Data Brief No. 561.
  • [2] Probi AB (2026, May 5). Probi enters the fast-growing postbiotic market with Rham271h launch at Vitafoods Europe.
  • [3] Consumer Affairs Agency, Japan (2026, July 3). Briefing session on the Foods with Function Claims system (Japanese).
  • [4] Kerry Group (2026, February 16). Plenibiotic: Supporting Digestive Comfort for a New Generation of GLP-1 Users.
  • [5] Lallemand Health Solutions (2025, May 15). Lallemand Health Solutions and Kirin Holdings Announce Distribution Agreement for Scientifically Proven Postbiotic IMMUSE.
  • [6] Lallemand Health Solutions (2026, April 3). Meet Lallemand Health Solutions at Vitafoods Barcelona 2026: Advancing Biotic Science Across Women’s Health, Healthy Aging, Cognitive Health, and Immunity.
  • [7] DSM-Firmenich (2026, February 20). Integrated Annual Report 2025 - Health, Nutrition & Care: Sustainability, innovation, and partnerships.
  • [8] Health Food Business (2026, September 9). HFMA urges Health Minister to take action over probiotic barriers.
  • [9] Food Standards Agency (2026, June 25). Food supplements guidance.
  • [10] Probi AB (2026, July 1). Probi celebrates 35 years of science and a new chapter with Symrise.
  • [11] Ministry of Food and Drug Safety, Republic of Korea (2026, August 13). Regulation on Recognition of Functional Ingredient and of Standard·Specification for Health Functional Foods (No. 2026-33).
  • [12] Novonesis (2026, September). Pylopass product page.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

This Report Answers

  • What will the Postbiotic Supplements Market size be in 2026, and what value will the forecast reach by 2036?
  • Which supplement-use habits will continue to support demand for postbiotic supplements?
  • Why will capsules and tablets hold the leading position within the Form category in 2026?
  • Why will online retailing lead the Sales Channel category?
  • How will growth rates differ across the UK, Germany, Japan, the USA, and South Korea till 2036?
  • How will shelf stability and heat-inactivated preparations change product design for supplement brands?
  • How will ingredient status, claim rules and GMP requirements slow new launches?
  • How will buyers assess the roles and capabilities of the profiled companies?
  • What will brand owners need to check before selecting a postbiotic ingredient supplier?

Table of Content

  1. Key Takeaways
    • Market Size and CAGR
    • Top Growth Driver
    • Fastest Growing Segment
    • Leading Region
    • Key Companies
    • Emerging Opportunities
  2. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
    • Analyst Perspective (What is happening? Why now? What should investors know?)
    • Key Questions Answered
      • How large is the market?
      • What is the CAGR?
      • What are key trends?
      • Which region dominates?
      • Who are the leaders?
Read More...
  1. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  2. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
      • Expert Input and Fieldwork (Primary Evidence)
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
    • Quality Assurance and Audit Trail
  3. Market Background
    • Market Dynamics (Drivers, Restraints, Opportunity, Trends)
    • Scenario Forecast (Optimistic, Likely, Conservative)
    • Impact Analysis
      • AI Impact
      • Sustainability Impact
      • Regulatory Impact
      • Technology Impact
    • Consumer / Buyer Analysis
      • Purchase Drivers
      • Adoption Barriers
      • Buyer Journey
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter's Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. Global Market Analysis and Forecast, 2021 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. Global Market Pricing Analysis, 2021 to 2036
  6. Global Market Analysis and Forecast, By Form, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Form, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Form, 2026 to 2036
      • Capsules and Tablets
      • Soft-gel and Chews
      • Powder and Granules
    • Y-o-Y Growth Trend Analysis By Form, 2021 to 2025
    • Absolute $ Opportunity Analysis By Form, 2026 to 2036
  7. Global Market Analysis and Forecast, By Sales Channel, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Sales Channel, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Sales Channel, 2026 to 2036
      • Online Retailing
      • Drug Store
      • Health and Beauty Store
      • Modern Trade
    • Y-o-Y Growth Trend Analysis By Sales Channel, 2021 to 2025
    • Absolute $ Opportunity Analysis By Sales Channel, 2026 to 2036
  8. Global Market Analysis and Forecast, By Region, 2021 to 2036
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East and Africa
    • Market Attractiveness Analysis By Region
  9. North America Market Analysis and Forecast, By Country, 2021 to 2036
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  10. Latin America Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  11. Western Europe Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  12. Eastern Europe Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  13. East Asia Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  14. South Asia and Pacific Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  15. Middle East and Africa Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
      • By Form
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Form
      • By Sales Channel
    • Key Takeaways
  16. Key Countries Market Analysis
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Form
        • By Sales Channel
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Form
        • By Sales Channel
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Form
        • By Sales Channel
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Form
        • By Sales Channel
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Form
        • By Sales Channel
  17. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Form
      • By Sales Channel
      • Emerging Startups
      • Innovation Benchmarking
    • Competition Analysis
      • Competition Deep Dive
        • DSM-Firmenich
          • Overview
          • Product Portfolio
          • Profitability by Market Segments
          • Sales Footprint
          • Strategy Overview
            • Marketing Strategy
            • Product Strategy
            • Channel Strategy
        • Novonesis
        • Kerry Group plc
        • Lallemand Inc.
        • Probi AB
        • Kirin Holdings Company, Limited
      • Case Studies
      • Success Stories
      • Recent Developments
  18. Assumptions & Acronyms Used

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 4: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 5: North America Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 6: North America Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 7: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 8: Latin America Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 9: Latin America Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 10: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 11: Western Europe Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 12: Western Europe Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 13: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 14: Eastern Europe Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 15: Eastern Europe Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 16: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 17: East Asia Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 18: East Asia Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 19: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 20: South Asia and Pacific Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 21: South Asia and Pacific Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 22: Middle East and Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 23: Middle East and Africa Market Value (USD Million) Forecast by Form, 2021 to 2036
  • Table 24: Middle East and Africa Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021-2036
  • Figure 3: Global Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 5: Global Market Attractiveness Analysis by Form
  • Figure 6: Global Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 8: Global Market Attractiveness Analysis by Sales Channel
  • Figure 9: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
  • Figure 11: Global Market Attractiveness Analysis by Region
  • Figure 12: North America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 13: Latin America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 14: Western Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 15: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 16: East Asia Market Incremental Dollar Opportunity, 2026-2036
  • Figure 17: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
  • Figure 18: Middle East and Africa Market Incremental Dollar Opportunity, 2026-2036
  • Figure 19: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 20: North America Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 21: North America Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 22: North America Market Attractiveness Analysis by Form
  • Figure 23: North America Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 24: North America Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 25: North America Market Attractiveness Analysis by Sales Channel
  • Figure 26: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 27: Latin America Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 28: Latin America Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 29: Latin America Market Attractiveness Analysis by Form
  • Figure 30: Latin America Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 31: Latin America Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 32: Latin America Market Attractiveness Analysis by Sales Channel
  • Figure 33: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 34: Western Europe Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 35: Western Europe Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 36: Western Europe Market Attractiveness Analysis by Form
  • Figure 37: Western Europe Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 38: Western Europe Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 39: Western Europe Market Attractiveness Analysis by Sales Channel
  • Figure 40: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 41: Eastern Europe Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 42: Eastern Europe Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 43: Eastern Europe Market Attractiveness Analysis by Form
  • Figure 44: Eastern Europe Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 45: Eastern Europe Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 46: Eastern Europe Market Attractiveness Analysis by Sales Channel
  • Figure 47: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 48: East Asia Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 49: East Asia Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 50: East Asia Market Attractiveness Analysis by Form
  • Figure 51: East Asia Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 52: East Asia Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 53: East Asia Market Attractiveness Analysis by Sales Channel
  • Figure 54: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 55: South Asia and Pacific Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 56: South Asia and Pacific Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 57: South Asia and Pacific Market Attractiveness Analysis by Form
  • Figure 58: South Asia and Pacific Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 59: South Asia and Pacific Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 60: South Asia and Pacific Market Attractiveness Analysis by Sales Channel
  • Figure 61: Middle East and Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 62: Middle East and Africa Market Value Share and BPS Analysis by Form, 2026 and 2036
  • Figure 63: Middle East and Africa Market Y-o-Y Growth Comparison by Form, 2026-2036
  • Figure 64: Middle East and Africa Market Attractiveness Analysis by Form
  • Figure 65: Middle East and Africa Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 66: Middle East and Africa Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 67: Middle East and Africa Market Attractiveness Analysis by Sales Channel
  • Figure 68: Global Market - Tier Structure Analysis
  • Figure 69: Global Market - Company Share Analysis

Frequently Asked Questions

How Big Is the Postbiotic Supplements Market Expected to Be in 2026?

According to FMI, postbiotic supplement revenue will total USD 14.5 Million in 2026, up from USD 13.0 Million in 2025, and will reach USD 44.2 Million by 2036 as supplement users add shelf-stable gut and immune products to daily routines.

What Is the CAGR of the Postbiotic Supplements Market from 2026 to 2036?

FMI projects an 11.8% CAGR for postbiotic supplement sales from 2026 to 2036, with new preparations backed by human data and wider gummy and powder formats setting the pace.

Which Form Holds the Largest Share of the Postbiotic Supplements Market?

Capsules and tablets will lead with 55.6% of form revenue in 2026. A fixed unit dose and existing encapsulation lines will keep the format ahead of chews and powders.

Which Sales Channel Leads the Postbiotic Supplements Market?

Online retailing will account for 41.2% of revenue in 2026, as product pages give brands room to describe a new category and build repeat orders.

Which Country Is Expected to Grow Fastest in the Postbiotic Supplements Market?

UK sales will grow fastest, at a 13.8% CAGR till 2036, with Germany close behind at 13.2% and South Korea last among the five profiled countries at 8.5%.

What Notable Restraint Affects the Postbiotic Supplements Market?

Country rules on ingredient status, claim wording and evidence will be the main restraint, adding qualification cost to each new launch. Japan applies GMP rules to supplement-form functional foods from September 2026, and South Korea limits labels to recognized functions.

Which Are the Key Companies in the Postbiotic Supplements Market?

DSM-Firmenich, Novonesis, Kerry Group plc, Lallemand Inc., Probi AB, and Kirin Holdings Company, Limited will feature among the profiled companies, grouped as integrated biotics platforms, postbiotic ingredient specialists, and strain owners and licensors.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Postbiotic Supplements Market